Bromodeoxyuridine improves the cytotoxic effect of cisplatin a comparison with 5-fluorouracil

Cancer Chemotherapy and Pharmacology

Volumn 40, Issue 6, 1997, Pages 463-468

  Chelladurai, Mohan ^a   Lobocki, Catherine A ^a   Sultani, Mtanius ^a   Hanna, Yoseff ^a   Drelichman, Anibal ^a   Pieper, David R ^a   McLaughlin, Patrick W ^a  

^a PROVIDENCE HOSPITAL   (United States)

Author keywords

Bromodeoxyuridine; Chemosensitizer; Cisplatin; Melanoma

Indexed keywords

BROXURIDINE; CISPLATIN; FLUOROURACIL; RADIOSENSITIZING AGENT;

AMELANOTIC MELANOMA; ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BODY WEIGHT; CELL CULTURE; CONTROLLED STUDY; DRUG RESISTANCE; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG METASTASIS; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; BROMODEOXYURIDINE; CISPLATIN; DRUG SYNERGISM; FLUOROURACIL; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; TUMOR CELLS, CULTURED;

EID: 0030751335     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050688     Document Type: Article

References (27)

1. Al-Sarraf M (1989) Clinical trials with fluorinated pyrimidines in patients with head and neck cancer. Cancer Invest 7: 71
2. Bernal S, Speak J, Boeheim J, Dreyfuss A, Wright J, Teicher B, Rosowsky A, Tsao S, Wong Y (1990) Reduced membrane protein associated with resistance of human squamous carcinoma cells to methotrexate and cis-platinum. Mol Cell Biochem 95: 61
3. Chu G (1994) Cellular responses to cisplatin. J Biol Chem 269: 787
4. Chu G, Chang E (1988) Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DNA. Science 242: 564
5. Chu G, Chang E (1990) Cisplatin resistant cells express increased levels of a factor that recognizes damaaed DNA. Proc Natl Acad Sci USA 87: 3324
6. Devita VT Jr (1993) Principles of chemotherapy. In: Devita VT Jr., Hellman S, Rosenberg SA (eds) Cancer, principles & practice of oncology. J. B. Lippincoft Company, Philadelphia, p 276
7. Dewey WC, Humphrey RM (1965) Increase in radiosensitivity to ionizing radiation related to replacement of thymidine in mammalian cells with 5-bromodeoxyuridine. Radiat Res 23: 538
8. Djordjevic B, Szbalski W (1960) Incorporation of 5-bromo- and 5-iodo-deoxyuridine into the deoxyribonucleic acid of human cells and effect on radiation sensitivity. J Exp Med 112: 509
9. Eastman A, Schulte N (1988) Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum. Biochemistry 27: 4730
10. Erickson RL, Szybalski W (1963) Radiation sensitizing properties of 5-iododeoxyuridine. Cancer Res 23: 122
11. Godwin A, Meister A, O'Dwyer P, Huang C, Hamilton T, Anderson M (1992) High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci USA 89: 3070
12. Goz B (1978) The effects of incorporation of 5-halogenated deoxyuridines into the DNA of eukaryotic cells. Pharm Rev 29: 249
13. Kase S, Kubota T, Watanabe M, Furukawa T, Tanino H, Ishibiki K, Teramoto T, Kitajima M (1993) Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo. Anticancer Res 13: 369-374
14. Kawai K, Kamatani N, Georges E, Ling V (1990) Identification of a membrane glycoprotein overexposed in murine lymphoma sublines resistant to cis-diamminedichloroplatinum. J Biol Chem 265: 13137
15. Kinsella T, Mitchell J, Russo A, Morstyn G, Glatstein E (1984) The use of halogenated thymidine analogues as clinical radio-sensitizers: rationale, current status, and future prospects. Int J Radiat Oncol Biol Phys 10: 1399
16. McLaughlin P, Mancini W, Stetson P, Greenberg H, Nguyen N, Seabury H, Heidorn D, Lawrence T (1993) Halogenated pyrimidine sensitization of low dose rate irradiation in human malignant glioma. Int J Radiat Oncol Biol Phys 26: 637
17. McLaughlin PW, Lawrence TS, Seaburg H, Nguye, N, Stetson P, Greenberg HS, Mancini W (1994) Bromodeoxyuridine-mediated radiosensitization in human glioma: the effect of concentration, duration and fluoropyrimidine modulation. Int J Radiat Oncol Biol Phys 30: 601
18. Mossman T (1983) Rapid colometric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Methods 65: 55-59
19. Onoda J, Nelson K, Taylor J, Honn K (1989) In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cis-diamminedichloroplatinum (II). Cancer Res 49: 2844
20. Parker R, Eastman A, Bostc-Bruton F, Reed E (1991) Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation. J Clin Invest 87: 772
21. Phillips T, Levin V, Ahn D, Gubn P, Davis R, Wilson C, Prados M, Wara W, Flam M (1991) Evaluation of bromo-de-oxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase 11 Study. Int J Radiat Oncol Biol Phys 21: 709
22. Russo A, DeGraff W, Kinsella TJ, Gamson J (1986) Potentiation of chemotherapy cytotoxicity following iododeoxy-uridine incorporation in Chinese hamster cells. Int J Radiat Oncol Biol Physics 12: 1371
23. Saikawa Y, Kubota T, Kuo T, Tanino H, Kase S, Furukawa T, Watanabe M, Ishibiki K, Kitajima M, Hoffman R (1994) Combined effect of 5-fluorouracil and carboplatin against human gastric cancer cell lines in vitro and in vivo. Anticancer Res 14: 461
24. Scanlon D, Newman E, Lu Y, Priest D (1984) Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci USA 83: 8923
25. Shimoyama Y, Kubota T, Watanabe M, Ishibiki K, Abe O (1989) Predictability of in vivo chemosensitivity by in vitro MTT assay with reference to the clonogenic assay. J Surg Oncol 41: 12
26. Tochner Z, Kinsella T, Rowland J, Gatstein (1989) Treatment of unresectable sarcomas of adults with hyper-fractionated irradiation and iododeoxyuridine. In: McNally, N.J., ed. Scientific basis of modern radiotherapy, BIR Report No. 19, London, UK: British Institute of Radiology, p 107
27. Yokes E, Ratain M, Mick R, McEvilly J, Haraf D, Kozlof F, Hamasaki V, Weichselbaum R, Panie W, Weing B, Berenz F (1993) Cisplatin, fluorouracil and leucovorin augmented by interferon alpha-2b in head and neck cancer: a clinical and pharmacologic analysis. J Clin Oncol 11: 360